At a glance
ClinicalIndex Comparison RecordN/ACompleted· 60 enrolled
Drug / intervention
EBUS TBNAdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of 19-gauge vs 21-gauge EBUS TBNA in Assessing Thoracic Lymphadenopathy
In Brief
A clinical study evaluating EBUS TBNA for Enlarged Lymph Nodes (Excluding Infective). Completed, enrolled 60 participants across 1 site.
Detailed Summary
This study compares the yield of 19-gauge needles vs 21-gauge needles during EBUS TBNA procedures.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
Enrollment StartJul 2018
First PostedSep 2018
Primary CompletionJan 2019
Study CompletionAug 2019
TodayJul 2026
First PostedSep 5, 2018
Enrollment StartJul 18, 2018
Primary CompletionJan 25, 2019
Study CompletionAug 31, 2019
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 7.8 years ago
Interventions
EBUS TBNAdevice
All patients undergo EBUS TBNA with two needle sizes